IRADIMED CORPORATION Announces Preliminary Financial Results for Fourth Quarter 2022
January 18, 2023 08:00 ET
|
iRadimed Corporation
Reports preliminary fourth quarter 2022 revenue of $14.9 millionAnnounces full-year and first-quarter 2023 financial guidance WINTER SPRINGS, Fla., Jan. 18, 2023 (GLOBE NEWSWIRE) -- IRADIMED...
IRADIMED CORPORATION Announces Third Quarter 2022 Financial Results
November 03, 2022 07:00 ET
|
iRadimed Corporation
Revenue was $13.4 million and increased by 23%Operating income was $4.1 million and increased 32%GAAP diluted EPS was $0.27 and increased by 35%Announces fourth quarter 2022 financial guidance WINTER...
IRADIMED CORPORATION to Hold 2022 Third Quarter Financial Results Conference Call on November 3rd
October 27, 2022 08:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Oct. 27, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 third quarter financial results before the market...
IRADIMED CORPORATION Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA
October 10, 2022 08:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Oct. 10, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that the Company voluntarily withdrew its 510(K) application on October 5,...
IRADIMED CORPORATION Announces Appointment of Hilda Scharen-Guivel to Board of Directors
October 06, 2022 16:05 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Oct. 06, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced the appointment of Hilda Scharen-Guivel to the Iradimed Board of...
IRADIMED CORPORATION Announces Second Quarter 2022 Financial Results
July 29, 2022 11:00 ET
|
iRadimed Corporation
Reports second quarter 2022 revenue of $12.7 million, GAAP diluted EPS of $0.26 and non-GAAP diluted EPS of $0.26Announces third quarter 2022 financial guidance WINTER SPRINGS, Fla., July 29, 2022 ...
UPDATE - IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th
July 28, 2022 13:57 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., July 28, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market...
IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th
July 22, 2022 16:30 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., July 22, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market...
IRADIMED Names John F. Glenn Chief Financial Officer
May 26, 2022 16:05 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., May 26, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that John (Jack) Glenn has been appointed Chief Financial Officer effective on or before...
IRADIMED CORPORATION Announces First Quarter 2022 Financial Results
April 29, 2022 07:00 ET
|
iRadimed Corporation
Reports first quarter 2022 revenue of $12.3 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.22Announces second quarter 2022 financial guidanceIncreases full-year 2022 financial...